Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
WIN-Partners Co., Ltd. ( (JP:3183) ) has provided an announcement.
WIN-Partners Co., Ltd. has disclosed the status of its ongoing share repurchase program authorized by its board on February 9, 2026 under the Companies Act of Japan. Between February 10 and February 28, the company bought back 118,000 ordinary shares on the Tokyo Stock Exchange for a total of 171.7 million yen, as part of a broader authorization to repurchase up to 290,000 shares or 400 million yen by March 31, 2026.
The buyback indicates management’s commitment to shareholder returns and capital efficiency, as the repurchased shares represent up to 1.0% of outstanding shares excluding treasury stock under the full authorization. By reducing the free float and potentially improving metrics such as earnings per share, the program may support the company’s share price and optimize its capital structure, which could be viewed positively by existing investors and market participants.
The most recent analyst rating on (JP:3183) stock is a Buy with a Yen1682.00 price target. To see the full list of analyst forecasts on WIN-Partners Co., Ltd. stock, see the JP:3183 Stock Forecast page.
More about WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd. is a Japan-based company listed on the Tokyo Stock Exchange. Operating in the healthcare and medical services-related sector, it focuses on providing specialized solutions and services to medical institutions and related markets, positioning itself as a stable, publicly traded player in its niche industry.
Average Trading Volume: 28,964
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen40.82B
See more data about 3183 stock on TipRanks’ Stock Analysis page.